Chemomab Therapeutics
Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases
Active
Public
Startup
Tel Aviv-Yafo
Founded 2011-11
Chemomab is a clinical stage biotechnology company discovering and developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a first-in-class monoclonal antibody designed to neutralize CCL24 acti…
SectorHealth Tech & Life Sciences
StagePublic
Total raised$90.5M
Employees19
Founded2011-11
HQTel Aviv-Yafo
Crunchbasechemomab
Patents1
Confidence98
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients